Monte Rosa Therapeutics
GLUE
#6712
Rank
A$1.11 B
Marketcap
A$13.05
Share price
-3.03%
Change (1 day)
-40.72%
Change (1 year)

Earnings for Monte Rosa Therapeutics (GLUE)

Earnings in 2026 (TTM): -A$0.2 Billion

According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are A$70.32 Million. In 2025 the company made an earning of -A$60.02 Million, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monte Rosa Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.2 Billion216.69%
2025 -A$60.02 Million-43.36%
2024 -A$0.11 Billion-48.06%
2023 -A$0.21 Billion24.43%
2022 -A$0.17 Billion46.71%
2021 -A$0.12 Billion106.13%
2020 -A$54.21 Million